A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.

A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.

HHS is investigating a potential problem with the first round of diagnostics for coronavirus after fears of contamination at a lab where government tests were sent. Timothy Stenzel, an FDA official and scientist who visited the government lab, sounded the alarm after witnessing procedures that concerned him.

Since the American College of Emergency Physicians launched the effort, participating EDs have saved some $55 million from avoiding unnecessary imaging and hospitalizations. 

Such occurrences are relatively rare in radiology, but even one case of patient harm is too many, experts argue, underlining the importance of staying on top of this issue. 

Two separate radiology providers recently relaunched their mammography services following lengthy suspensions, triggered by FDA and ACR concerns. 

A new investigation examining how marketers are getting the personal Medicare information of seniors is underway, with government watchdogs wanting to know if a misuse of a government system is to blame, The Associated Press reported.

These measures were developed by a working group of clinicians and provide radiologists with a new opportunity to score incentives, officials said.